BSECompany Update5d ago · 6 Nov 2026, 11:23 am
Submission of financial results published in newspapers.
Aurobindo Pharma Ltd · 524804
✦ AI SummaryResults
Aurobindo Pharma Ltd has submitted its financial results for the second quarter and half year ended September 30, 2026, as published in Business Standard and Nava Telangana on November 6, 2026.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk3/10
Liquidity Impact8/10
Market Sentiment6/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Aurobindo Pharma Ltd - 524804 - Announcement under Regulation 30 (LODR)-Newspaper Publication